Position in NBIX
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$3,025,461
+$1,554,190 QoQ
Shares Held
17,951
+60.7% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#264
of 772 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 43%
Shared 0%
None 57%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026TRUIST FINANCIAL CORP holds $42,596,492 across 20 Drug Manufacturers - Specialty & Generic names. NBIX ranks #6 (7.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
392,480 | $13,297,221 | |
| 2 | ZTS |
Zoetis Inc.
|
116,123 | $8,344,597 | |
| 3 | HLN |
Haleon plc
|
504,080 | $4,703,065 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
6,217 | $3,368,556 | |
| 5 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
51,671 | $3,304,360 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
This page
|
17,951 | $3,025,461 | |
| 7 | TAK |
Takeda Pharmaceutical Co Ltd
|
71,842 | $1,151,626 | |
| 8 | VTRS |
Viatris Inc
|
61,364 | $974,459 |
All Filings in NBIX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,025,461 | 17,951 | Shares | Defined | 2026-07-28 | |
| 2026-03-31 | $1,471,271 | 11,168 | Shares | Defined | 2026-04-27 | |
| 2025-12-31 | $1,558,852 | 10,991 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $4,958,782 | 35,324 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $5,027,724 | 40,001 | Shares | Defined | 2025-07-18 | |
| 2025-03-31 | $3,902,630 | 35,286 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $6,337,012 | 46,425 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $24,689,686 | 214,283 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $4,342,937 | 31,546 | Shares | Defined | 2024-08-21 | |
| 2024-03-31 | $5,151,036 | 37,348 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $4,900,812 | 37,195 | Shares | Defined | 2024-02-02 | |
| 2023-09-30 | $4,024,349 | 35,772 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $3,334,163 | 35,357 | Shares | Defined | 2023-08-01 | |
| 2023-03-31 | $4,211,864 | 41,611 | Shares | Defined | 2023-05-05 | |
| 2022-12-31 | $5,056,849 | 42,338 | Shares | Defined | 2023-02-17 | |
| 2022-09-30 | $4,680,567 | 44,069 | Shares | Defined | 2022-10-26 | |
| 2022-06-30 | $4,901,196 | 50,279 | Shares | Defined | 2022-07-22 | |
| 2022-03-31 | $5,741,718 | 61,245 | Shares | Defined | 2022-04-22 | |
| 2021-12-31 | $3,663,928 | 43,019 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $4,342,420 | 45,276 | Shares | Defined | 2021-11-05 | |
| 2021-06-30 | $4,233,905 | 43,505 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $4,460,759 | 45,869 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $4,212,030 | 43,944 | Shares | Defined | 2021-11-19 | |
| 2020-09-30 | $4,282,772 | 44,538 | Shares | Defined | 2021-11-05 | |
| 2020-06-30 | $5,046,652 | 41,366 | Shares | Defined | 2021-11-16 | |
| 2020-03-31 | $3,531,497 | 40,803 | Shares | Defined | 2021-11-05 | |
| No filing history on record for this holder in this stock. | ||||||